These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1659424)
1. Increased proteolytic activity on the surface of monocytes from patients with rheumatoid arthritis. Kirchheimer JC; Remold HG; Wanivenhaus A; Binder BR Arthritis Rheum; 1991 Nov; 34(11):1430-3. PubMed ID: 1659424 [TBL] [Abstract][Full Text] [Related]
2. Modulation of receptor bound urokinase-type plasminogen activator on human monocytes by non-steroidal antiinflammatory drugs. Kirchheimer JC Scand J Rheumatol; 1993; 22(2):53-7. PubMed ID: 8386851 [TBL] [Abstract][Full Text] [Related]
3. Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis. Slot O; Brünner N; Locht H; Oxholm P; Stephens RW Ann Rheum Dis; 1999 Aug; 58(8):488-92. PubMed ID: 10419867 [TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis. Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829 [TBL] [Abstract][Full Text] [Related]
5. Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints. Busso N; Péclat V; So A; Sappino AP Ann Rheum Dis; 1997 Sep; 56(9):550-7. PubMed ID: 9370880 [TBL] [Abstract][Full Text] [Related]
6. Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis. Guiducci S; Del Rosso A; Cinelli M; Perfetto F; Livi R; Rossi A; Gabrielli A; Giacomelli R; Iori N; Fibbi G; Del Rosso M; Cerinic MM Arthritis Res Ther; 2005; 7(6):R1244-53. PubMed ID: 16277677 [TBL] [Abstract][Full Text] [Related]
7. Urokinase-catalyzed plasminogen activation at the monocyte/macrophage cell surface: a localized and regulated proteolytic system. Vassalli JD; Wohlwend A; Belin D Curr Top Microbiol Immunol; 1992; 181():65-86. PubMed ID: 1330446 [No Abstract] [Full Text] [Related]
8. [Increase of the membrane-bound urokinase level in monocytes from patients with atherosclerosis is accompanied by decrease of urokinase-induced myocyte migration]. Arefieva TI; Krasnikova TL; Parfenova EV; Alekseeva IA Biull Eksp Biol Med; 1998 Aug; 126(8):147-9. PubMed ID: 9777222 [No Abstract] [Full Text] [Related]
9. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation. Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164 [TBL] [Abstract][Full Text] [Related]
11. Synoviocytes from osteoarthritis and rheumatoid arthritis produce plasminogen activators and plasminogen activator inhibitor-1 and display u-PA receptors on their surface. Cerinic MM; Generini S; Partsch G; Pignone A; Dini G; Konttinen YT; Del Rosso M Life Sci; 1998; 63(6):441-53. PubMed ID: 9718068 [TBL] [Abstract][Full Text] [Related]
12. Clinical correlation with the PA/plasmin system in septic arthritis of the knee. Hsieh YS; Yang SF; Lue KH; Lu KH Clin Orthop Relat Res; 2006 Jun; 447():172-8. PubMed ID: 16505706 [TBL] [Abstract][Full Text] [Related]
13. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee. Chu SC; Yang SF; Lue KH; Hsieh YS; Hsiao TY; Lu KH J Rheumatol; 2006 Feb; 33(2):311-7. PubMed ID: 16465663 [TBL] [Abstract][Full Text] [Related]
15. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Stoppelli MP; Corti A; Soffientini A; Cassani G; Blasi F; Assoian RK Proc Natl Acad Sci U S A; 1985 Aug; 82(15):4939-43. PubMed ID: 2991901 [TBL] [Abstract][Full Text] [Related]
16. Expression and localization of the urokinase-type plasminogen activator receptor (uPAR) in the human placenta. Nishida Y; Hayashi Y; Imai Y; Itoh H Kobe J Med Sci; 1998 Feb; 44(1):31-43. PubMed ID: 9846056 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-1beta-induced expression of the urokinase-type plasminogen activator receptor and its co-localization with MMPs in human articular chondrocytes. Schwab W; Schulze-Tanzil G; Mobasheri A; Dressler J; Kotzsch M; Shakibaei M Histol Histopathol; 2004 Jan; 19(1):105-12. PubMed ID: 14702177 [TBL] [Abstract][Full Text] [Related]
18. Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. Del Rosso A; Cinelli M; Guiducci S; Pignone A; Fibbi G; Margheri F; Gabrielli A; Giacomelli R; Coppini A; Del Rosso M; Matucci Cerinic M Rheumatology (Oxford); 2005 Oct; 44(10):1255-62. PubMed ID: 15998634 [TBL] [Abstract][Full Text] [Related]
19. Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial fibroblasts. Serratì S; Margheri F; Chillà A; Neumann E; Müller-Ladner U; Benucci M; Fibbi G; Del Rosso M Arthritis Rheum; 2011 Sep; 63(9):2584-94. PubMed ID: 21547898 [TBL] [Abstract][Full Text] [Related]
20. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues. Costantini V; Sidoni A; Deveglia R; Cazzato OA; Bellezza G; Ferri I; Bucciarelli E; Nenci GG Cancer; 1996 Mar; 77(6):1079-88. PubMed ID: 8635127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]